|
|
George Adrian Calin. M.D., Ph.D.
University of Texas MD Anderson Cancer Center |
GENETICS
Development of a new diagnostic and prognostic assay for CLL patients- quantification of plasma/serum microRNAs
Update:
No update is available at this time. Please check back soon.
|